Clinical trialNCT05865301RecruitingObservational

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

SponsorStanford UniversityEnrollment500Lymphoid Leukemia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To use a consistent and standardized platform to retrospectively and prospectively study children and young adults with B cell malignancies receiving Immunotherapy, blinatumomab and/or inotuzumab ozogamicin.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Kara Davis, MD
Stanford University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner University Medical Center - Tucson
Tucson, Arizona, United States
Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California, United States
Recruiting
Stanford University
Palo Alto, California, United States
Kara Davis, MD
Recruiting
Ucsf (benioff Children'S)
San Francisco, California, United States
Recruiting
Nemours Children'S Hospital
New Castle, Delaware, United States
Recruiting
University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
Recruiting
Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
Recruiting
Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
Recruiting
Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting
Corewell Health Grand Rapids Hospitals - Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
Recruiting
St. Louis Children'S (washington University)
St Louis, Missouri, United States
Recruiting
Children'S Hospital at Montefiore
The Bronx, New York, United States
Recruiting
Atrium Health Levine Cancer Institute
Charlotte, North Carolina, United States
Recruiting
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Recruiting
Ohsu Knight Cancer Institute
Portland, Oregon, United States
BIll Chang, MD
Recruiting
Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
Recruiting
Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
Recruiting
Cook Children'S Medical Center
Fort Worth, Texas, United States
Recruiting
Saint Jude Children'S Research Hospital
Fairfax, Virginia, United States
Recruiting
Seattle Children'S Hospital
Seattle, Washington, United States
Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Jun 2023
Primary completion: 30 Apr 2027
Completion: 31 Dec 2038
Last update posted: 4 Jun 2026
Registered enrollment: 500
Registry id: NCT05865301

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.